Cornercap Investment Counsel’s Alexion Pharmaceuticals ALXN Stock Holding History

Cornercap Investment Counsel’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-2,469	Closed	-$454K	–	630
2021 Q2	$454K	Sell	2,469 -295	-11%	-$50.6K	0.05%	486
2021 Q1	$423K	Sell	2,764 -25,027	-90%	-$3.87M	0.05%	480
2020 Q4	$3.01M	Sell	27,791 -2,137	-7%	-$275K	0.43%	72
2020 Q3	$3.42M	Sell	29,928 -733	-2%	-$79.1K	0.48%	45
2020 Q2	$3.44M	Sell	30,661 -621	-2%	-$65.9K	0.56%	39
2020 Q1	$2.81M	Buy	31,282 +73	+0.2%	+$7.16K	0.55%	45
2019 Q4	$3.38M	Buy	31,209 +624	+2%	+$66.7K	0.45%	68
2019 Q3	$3M	Buy	30,585 +7,080	+30%	+$798K	0.42%	81
2019 Q2	$3.08M	Buy	23,505 +8,185	+53%	+$1.05M	0.41%	82
2019 Q1	$2.07M	Buy	+15,320	New	+$1.9M	0.29%	109
2018 Q1	–	Sell	-14,545	Closed	-$1.74M	–	463
2017 Q4	$1.74M	Buy	+14,545	New	+$1.77M	0.24%	124

Other funds holding ALXN

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return

TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return

CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return

Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return